Larvol Delta - Clinical-update-anticipated-in-mid2026-for-Phase-1-autoimmune-program-evaluating-prulacabtagene-leucel-prulacel-formerly-ADI001-with-at-least-20-lupus-nephritis-LN-and-systemic-lupus-erythematosus-SLE-patients-with-a-minimum-of-six-months-followup

prulacabtagene leucel (ADI-001) - Adicet Bio

https://crisprmedicinenews.com/press-release-service/card/adicet-bio-reports-first-quarter-2026-financial-results-and-provides-business-updates/

May 14, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next